Replies to post #99936 on OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

Continuing to strongly confirm that OWCP top management have skin in the game.

1/3 of their ESOs are vested, however: "They may not be exercised within the first two years after the date of grant"

-therefore-

2/3 are not vested

and cannot vest for 2 years after ESOP was issued except that 8.33% of ESOs will vest quarterly.
The ESOP was granted December 15, 2016, and will vest December 15, 2018.

1/3 of their ESOs are vested, however: "They may not be exercised within the first two years after the date of grant". I like the ESOP and was relieved to see it in the last 10-K. Good for them for being compensated since the only salary taken up through Dec 31, 2016 was by the CEO Mordechai Bignitz which amounted to $12,000 for the entire year of 2015 and $36,000 for the year of 2016.


2/3 of their ESOs are not vested and all of the ESOs from this ESOP are restricted. "They may not be exercised within the first two years after the date of grant"... hence they have a lot of skin in the game.